EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cold fingers under the lens: unveiling microvascular differences between children with primary Raynaud’s phenomenon and healthy individuals

Gülşah Kavrul Kayaalp iD, Selen Duygu Arık iD, Özlem Akgün iD, Bengisu Menentoğlu iD, Ayşenur Doğru iD, Figen Çakmak iD, Nuray Aktay Ayaz iD

Modern Rheumatology · 2025

DOI: 10.1093/mr/roaf089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Gülşah Kavrul Kayaalp und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Raynaud Disease, Fingers. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to evaluate capillaroscopic findings in children with Raynaud’s phenomenon (RP) referred to a paediatric rheumatology clinic and compare them to healthy controls to identify RP-related patterns.

Methods

Sixty-six patients aged 0–18 years with RP and 65 age- and sex-matched healthy controls were included. Standardized capillaroscopic assessments followed the 2020 recommendations of EULAR study group on microcirculation in rheumatic diseases. Capillaroscopic patterns of 62 primary RP patients were compared with controls.

Results

Two patients were diagnosed with systemic sclerosis and two with systemic lupus erythematosus. Among 62 primary RP patients (median age 14.92 years, 62.9% female), antinuclear antibody positivity was 11.29%. Capillaroscopy revealed increased apical loop diameter (18.74 ± 4.40 vs. 15.20 ± 2.98, P < .001), dilated capillaries (82.3% vs. 15.40%, P < .001), abnormal capillaries (53.2% vs. 18.5%, P < .001), microhemorrhages (17.7% vs. 1.5%, P = .002) in primary RP patients compared to controls. The predominant pattern was non-specific (56.5%) in RP patients and normal pattern in controls (87.7%, P < .001). No correlation was found between capillaroscopy patterns and antinuclear antibody positivity or medication use.

Conclusions

Patients with primary RP showed a unique capillaroscopy pattern. Follow-up studies are needed to assess the proportion who may develop secondary RP and how capillaroscopic findings evolve.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Raynaud DiseaseFingersHumansFemaleMaleChildAdolescentMicroscopic AngioscopyChild, PreschoolInfantMicrocirculationCase-Control StudiesCapillariesAntibodies, Antinuclear

Stichwörter der Autor:innen

Raynaud’s phenomenonconnective tissue diseasesnailfold capillaroscopypaediatric rheumatologysystemic sclerosis

Substanzen

Antibodies, Antinuclear

Autor:innen und Institutionen

  • Department of Pediatric Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Türkiye.

ORCID-Profile: Gülşah Kavrul Kayaalp, Selen Duygu Arık, Özlem Akgün, Bengisu Menentoğlu, Ayşenur Doğru, Figen Çakmak, Nuray Aktay Ayaz

Zitieren

APA

Kavrul Kayaalp, G., Arık, S. D., Akgün, Ö., Menentoğlu, B., Doğru, A., Çakmak, F., & Aktay Ayaz, N. (2025). Cold fingers under the lens: unveiling microvascular differences between children with primary Raynaud’s phenomenon and healthy individuals. Modern Rheumatology. https://doi.org/10.1093/mr/roaf089

Vancouver

Kavrul Kayaalp G, Arık SD, Akgün Ö, Menentoğlu B, Doğru A, Çakmak F, et al. Cold fingers under the lens: unveiling microvascular differences between children with primary Raynaud’s phenomenon and healthy individuals. Modern Rheumatology. 2025. doi:10.1093/mr/roaf089

BibTeX
@article{KavrulKayaalp2025,
  author = {Kavrul Kayaalp, Gülşah and Arık, Selen Duygu and Akgün, Özlem and Menentoğlu, Bengisu and Doğru, Ayşenur and Çakmak, Figen and Aktay Ayaz, Nuray},
  title = {Cold fingers under the lens: unveiling microvascular differences between children with primary Raynaud’s phenomenon and healthy individuals},
  journal = {Modern Rheumatology},
  year = {2025},
  doi = {10.1093/mr/roaf089}
}
Kostenlos starten →